申请人:Basu Arnab
公开号:US09101635B2
公开(公告)日:2015-08-11
Organic compounds showing the ability to inhibit viral glycoprotein (GP)-mediated entry of a filovirus into a host cell are disclosed. The disclosed filovirus entry inhibitor compounds are useful for treating, preventing, or reducing the spread of infections by filovirus including the type species Marburg virus (MARV) and Ebola virus (EBOV). Preferred inhibitors of the invention provide therapeutic agents for combating the Ivory Coast, Sudan, Zaire, Bundibugyo, and Reston Ebola virus strains.
揭示了一种有能力抑制病毒糖蛋白(GP)介导的丝状病毒进入宿主细胞的有机化合物。所述的丝状病毒进入抑制剂化合物可用于治疗、预防或减少丝状病毒(包括马尔堡病毒(MARV)和埃博拉病毒(EBOV)等类型物种)感染的传播。该发明的首选抑制剂为治疗象牙海岸、苏丹、扎伊尔、班迪布约和雷斯顿埃博拉病毒株提供了治疗药物。